153 related articles for article (PubMed ID: 37116543)
1. A MnAl double adjuvant nanovaccine to induce strong humoral and cellular immune responses.
Qiao N; Wang H; Xu Y; Chang Y; Xie M; Bai S; He C; Qin M; Zhong X; Jiang M; Guo Z; Du G; Zhang Z; Zhang Y; Sun X
J Control Release; 2023 Jun; 358():190-203. PubMed ID: 37116543
[TBL] [Abstract][Full Text] [Related]
2. MnO
Song T; Liao Y; Zuo Q; Liu N; Liu Z
J Mater Chem B; 2022 May; 10(18):3474-3490. PubMed ID: 35403638
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
Jin JW; Tang SQ; Rong MZ; Zhang MQ
Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Dendritic Cell Activation Through Manganese-Coated Nanovaccine Targeting the cGAS-STING Pathway.
Wang Q; Gao Y; Li Q; He A; Xu Q; Mou Y
Int J Nanomedicine; 2024; 19():263-280. PubMed ID: 38226319
[TBL] [Abstract][Full Text] [Related]
5. Smart combination of aluminum hydroxide and MF59 to induce strong cellular immune responses.
Chen Z; Hao X; Wang H; Zhong X; Chen X; Zhao Y; Zhang Y; Du G; Sun X
J Control Release; 2022 Sep; 349():699-711. PubMed ID: 35907590
[TBL] [Abstract][Full Text] [Related]
6. Potentiating humoral and cellular immunity using a novel hybrid polymer-lipid nanoparticle adjuvant for HBsAg-VLP vaccine.
Liu X; Min Q; Song H; Yue A; Li Q; Zhou Q; Han W
J Nanobiotechnology; 2023 Nov; 21(1):441. PubMed ID: 37993870
[TBL] [Abstract][Full Text] [Related]
7. An aluminum adjuvant-integrated nano-MOF as antigen delivery system to induce strong humoral and cellular immune responses.
Zhong X; Zhang Y; Tan L; Zheng T; Hou Y; Hong X; Du G; Chen X; Zhang Y; Sun X
J Control Release; 2019 Apr; 300():81-92. PubMed ID: 30826373
[TBL] [Abstract][Full Text] [Related]
8. Manganese salts function as potent adjuvants.
Zhang R; Wang C; Guan Y; Wei X; Sha M; Yi M; Jing M; Lv M; Guo W; Xu J; Wan Y; Jia XM; Jiang Z
Cell Mol Immunol; 2021 May; 18(5):1222-1234. PubMed ID: 33767434
[TBL] [Abstract][Full Text] [Related]
9. Orchestrated Cytosolic Delivery of Antigen and Adjuvant by Manganese Ion-Coordinated Nanovaccine for Enhanced Cancer Immunotherapy.
Gao ZL; Xu W; Zheng SJ; Duan QJ; Liu R; Du JZ
Nano Lett; 2023 Mar; 23(5):1904-1913. PubMed ID: 36801829
[TBL] [Abstract][Full Text] [Related]
10. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections.
Chen H; Li Y; Li L; Yang Z; Wen Z; Liu L; Liu H; Chen Y
Acta Biomater; 2023 Mar; 158():525-534. PubMed ID: 36572250
[TBL] [Abstract][Full Text] [Related]
11. Advances of MnO
Zhang T; Hu C; Zhang W; Ruan Y; Ma Y; Chen D; Huang Y; Fan S; Lin W; Huang Y; Liao K; Lu H; Xu JF; Pi J; Guo X
Front Immunol; 2023; 14():1156239. PubMed ID: 37153576
[TBL] [Abstract][Full Text] [Related]
12. Chitosan derivative composite nanoparticles as adjuvants enhance the cellular immune response via activation of the cGAS-STING pathway.
Zhao Z; Peng Y; Shi X; Zhao K
Int J Pharm; 2023 Apr; 636():122847. PubMed ID: 36933583
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
Schmidt ST; Olsen CL; Franzyk H; Wørzner K; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
Eur J Pharm Biopharm; 2019 Jul; 140():29-39. PubMed ID: 31055066
[TBL] [Abstract][Full Text] [Related]
14. Simple nanoliposomes encapsulating
Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
[TBL] [Abstract][Full Text] [Related]
15. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
16. The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
Volckmar J; Knop L; Stegemann-Koniszewski S; Schulze K; Ebensen T; Guzmán CA; Bruder D
Vaccine; 2019 Aug; 37(35):4963-4974. PubMed ID: 31320219
[TBL] [Abstract][Full Text] [Related]
17. Construction of lymph nodes-targeting tumor vaccines by using the principle of DNA base complementary pairing to enhance anti-tumor cellular immune response.
Zha Y; Fu L; Liu Z; Lin J; Huang L
J Nanobiotechnology; 2024 May; 22(1):230. PubMed ID: 38720322
[TBL] [Abstract][Full Text] [Related]
18. Delivery of STING agonists for adjuvanting subunit vaccines.
Van Herck S; Feng B; Tang L
Adv Drug Deliv Rev; 2021 Dec; 179():114020. PubMed ID: 34756942
[TBL] [Abstract][Full Text] [Related]
19. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy.
Su Q; Liu Z; Du R; Chen X; Chen L; Fu Z; Luo X; Yang Y; Shi X
Acta Biomater; 2023 Mar; 158():510-524. PubMed ID: 36603733
[TBL] [Abstract][Full Text] [Related]
20. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant for H9N2 vaccine to improve immune responses in chickens compared to Alum and oil-based adjuvants.
Gu P; Wusiman A; Zhang Y; Cai G; Xu S; Zhu S; Liu Z; Hu Y; Liu J; Wang D
Vet Microbiol; 2020 Dec; 251():108894. PubMed ID: 33096470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
